Clinical Trials Directory

Trials / Terminated

TerminatedNCT01577810

Near Infrared Spectroscopy (NIRS) for Heart Failure Assessment.

Near Infrared Spectroscopy (NIRS) for Heart Failure Assessment in the Outpatient Setting

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
3 (actual)
Sponsor
Phoenix Children's Hospital · Academic / Other
Sex
All
Age
1 Day – 18 Years
Healthy volunteers
Not accepted

Summary

It is routine practice for a cardiologist to perform a battery of tests to assess the degree of heart failure. The purpose of this study is to establish a non-invasive method to reliably predict cardiac output state in real-time in children and adolescents with heart failure in an outpatient setting. This study will rely on the use of near infrared spectroscopy monitors to measure cardiac output in the outpatient setting.

Detailed description

Near-infrared spectroscopy (NIRS) technology, such as that used in pulse oximetry, has been used in medicine for decades. Several characteristics contribute to its widespread use, including its noninvasive nature, reliability and safety. The Somanetics' INVOS® System harnesses this power to safely and reliably "see inside" the brain and body. NIRS devices measure the venous weighted oxy-hemoglobin saturation (color of blue blood) in a field of tissue, rather than in arteries, and thus the rSO2 parameter provides a window into regional oxygen supply-demand relationships. Monitoring rSO2 at two distinct sites (cerebral and somatic) has become common practice at our institution for all infants and children in the intensive care unit and provides valuable feedback about potentially deleterious trends in regional tissue oxygenation that cannot easily be obtained by other modalities in such patients.

Conditions

Interventions

TypeNameDescription
DEVICENear Infrared SpectroscopyUse of Near Infrared Spectroscopy in outpatient setting to determine global cardiac output

Timeline

Start date
2013-06-01
Primary completion
2017-04-05
Completion
2017-04-05
First posted
2012-04-16
Last updated
2025-11-24

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01577810. Inclusion in this directory is not an endorsement.